Adepoju Victor Abiola, Adelekan Ademola, Agbaje Aderonke, Quaitey Femi, Ademola-Kay Tobi, Udoekpo Ann Uduak, Sokoya Olusola Daniel
Department of HIV and Infectious Diseases, Jhpiego Nigeria, Federal Capital Territory, Abuja 900918, Nigeria.
Department of Research, Bluegate Research Institute, Ibadan 211271, Oyo State, Nigeria.
World J Clin Cases. 2023 Jan 6;11(1):104-115. doi: 10.12998/wjcc.v11.i1.104.
Nigeria is one of the thirty high burden countries with significant contribution to the global childhood tuberculosis epidemic. Tuberculosis annual risk for children could be as high as 4% particularly in high tuberculosis (TB) prevalent communities. Isoniazid (INH) Preventive Therapy has been shown to prevent TB incidence but data on its implementation among children are scarce.
To determine the completion of INH among under six children that were exposed to adults with smear positive pulmonary TB in Lagos, Nigeria.
This was a hospital-based retrospective cross-sectional review of 265 medical records of eligible children < 6 years old enrolled for INH across 32 private hospitals in Lagos, Nigeria. The study took place between July and September 2020. Data was collected on independent variables (age, gender, type of facility, TB screening, dose and weight) and outcome variables (INH outcome and proportion lost to follow up across months 1-6 of INH treatment).
About 53.8% of the participants were female, 95.4% were screened for TB and none was diagnosed of having TB. The participants' age ranged from 1 to 72 mo with a mean of 36.01 ± 19.67 mo, and 40.2% were between the ages of 1-24 mo. Only 155 (59.2%) of the 262 participants initiated on INH completed the six-month treatment. Cumulatively, 107 (41.0%) children were lost to follow-up at the end of the sixth month. Of the cumulative 107 loss to follow-up while on INH, largest drop-offs were reported at the end of month 2, 52 (49%) followed by 20 (19%), 17 (16%), 11 (10.2%) and 7 (6.5%) at months 3, 4, 5 and 6 respectively. The analysis showed that there was no significant association between age, gender, type of facility and completion of INH treatment ( > 0.005).
This study demonstrated suboptimal INH completion rate among children with only 6 out of 10 children initiated on INH who completed a 6-mo treatment in Lagos, Nigeria. The huge drop-offs in the first 2 mo of INH calls for innovative strategies such as the use of 60-d INH calendar that would facilitate reminder and early engagement of children on INH and their caregivers in care and across the entire period of treatment.
尼日利亚是全球儿童结核病流行负担较重的30个国家之一,对全球儿童结核病疫情有重大影响。儿童结核病的年风险可能高达4%,尤其是在结核病高发社区。异烟肼预防性治疗已被证明可预防结核病发病,但关于其在儿童中实施的数据却很匮乏。
确定在尼日利亚拉各斯接触涂片阳性肺结核成人的6岁以下儿童中异烟肼治疗的完成情况。
这是一项基于医院的回顾性横断面研究,对尼日利亚拉各斯32家私立医院登记接受异烟肼治疗的265名6岁以下合格儿童的病历进行分析。研究于2020年7月至9月进行。收集了独立变量(年龄、性别、医疗机构类型、结核病筛查、剂量和体重)和结果变量(异烟肼治疗结果以及异烟肼治疗第1至6个月失访比例)的数据。
约53.8%的参与者为女性,95.4%接受了结核病筛查,且均未被诊断患有结核病。参与者年龄在1至72个月之间,平均年龄为36.01±19.67个月,40.2%的儿童年龄在1至24个月之间。在262名开始接受异烟肼治疗的参与者中,只有155名(59.2%)完成了6个月的治疗。累计有107名(41.0%)儿童在第6个月末失访。在接受异烟肼治疗期间累计失访的107名儿童中,第2个月末失访人数最多,为52名(49%),其次是第3、4、5和6个月末分别有20名(19%)、17名(16%)、11名(10.2%)和7名(6.5%)。分析表明,年龄、性别、医疗机构类型与异烟肼治疗的完成情况之间无显著关联(P>0.005)。
本研究表明,在尼日利亚拉各斯,接受异烟肼治疗的儿童中完成率不理想,开始接受异烟肼治疗的儿童中只有十分之六完成了6个月的治疗。异烟肼治疗前两个月的大量失访情况需要创新策略,如使用60天的异烟肼日历,这将有助于提醒并促使儿童及其照顾者在整个治疗期间尽早参与到异烟肼治疗中。